Financial Consulate’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3K Sell
434
-6
-1% -$418 ﹤0.01% 431
2025
Q4
$29.2K Buy
440
+10
+2% +$647 ﹤0.01% 402
2025
Q3
$28.9K Buy
+430
New +$34K ﹤0.01% 394

Other funds holding DXCM

Financial Consulate's DXCM Position: Q1 2026 in Review

Financial Consulate reduced its DexCom (DXCM) stake by 1.4% in Q1 2026, selling an estimated $418 and leaving 434 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

Financial Consulate first reported a position in DXCM in Q3 2025 and has held it in 3 quarters since. The position peaked at $29.2K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Financial Consulate held 434 shares of DexCom worth $27.3K as of Q1 2026.
  • Financial Consulate sold 6 DexCom shares in Q1 2026, an estimated $418.
  • DexCom made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #431 holding.
  • Financial Consulate first reported a position in DexCom in Q3 2025 and has held it in 3 quarters since.
  • Financial Consulate's DexCom position peaked at $29.2K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.